Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq of HA-METTL14 in HepG2 cells

ABSTRACT: ChIP-seq of HA-METTL14 in HepG2 cells

PROVIDER: PRJNA499113 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8131600.fastq.gz	Fastqsanger.gz
	SRR8131595.fastq.gz	Fastqsanger.gz
	SRR8131596.fastq.gz	Fastqsanger.gz
	SRR8131597.fastq.gz	Fastqsanger.gz
	SRR8131598.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

ChIP-seq of HA-METTL14 in HepG2 cells

Project description:The METTL3-METTL14 heterodimer is the core component of the N6-methyltransferase complex (MTC) that catalyzes methylation of adenosine residues at the N(6) position of RNA. As the non-catalytic subunit of the MTC, METTL14 functions as the RNA-binding scaffold that recognizes the RNA substrate. We found METTL14 could interacte with chromatin through recognition of H3K36me3. ChIP-seq with HA-tagged METTL14 using an HA antibody identified 300 peaks in HepG2 cells, among which 53% peaks were located in the gene body and only 3% peaks were located in the promoter. The binding sites of METTL14 on chromatin correlate with that of H3K36me3.To investigat whether this interaction is Pol II dependent, we treated cells with a Pol II inhibitor 5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside (DRB) for a short time. Interestingly, we found the interaction of METTL14 with chromatin in gene body region was not affected by DRB treatment .

2019-02-21 | GSE121943 | GEO

PAR-CLIP-seq of HA-METTL14 in HepG2 cells

2019-02-21 | GSE121948 | GEO

PAR-CLIP-seq of HA-METTL14 in HepG2 cells

Project description:PAR-CLIP-seq of HA-METTL14 in HepG2 cells

| PRJNA499119 | ENA

RNA stability profiling in SETD2 and METTL14 knockdown HepG2 cells

Project description:To evaluate the effect of SETD2 and METTL14 on mRNA stability, we conducted RNA-seq in SETD2 or METTL14 knockdown HepG2 cells as well as control cells with or without actinomycin D treatment. Our RNA stability profiling revealed that depletion of SETD2 and METTL14 resulted in global reduction of RNA stability, and the changes were correlated between SETD2 and METTL14 knockdown cells.

2019-02-21 | GSE121949 | GEO

Active ribosome profiling in SETD2 or METTL14 knockdown HepG2 cells

Project description:SETD2 is the specific methyltransferase of H3K36me3, while METTL14 is a critical subunit of the m6A methyltransferase complex. To evaluate the effect of SETD2 and METTL14 on translation, we conducted robosome profiling in SETD2 and METTL14 knockdown and control HepG2 cells. Our RNA ribosome profiling revealed that depletion of SETD2 and METTL14 resulted in a global reduction in RNA translation and the changes of translation efficiency were correlated between SETD2 and METTL14 knockdown cells.

2019-02-21 | GSE121952 | GEO

RNA stability profiling in SETD2 and METTL14 knockdown HepG2 cells

Project description:RNA stability profiling in SETD2 and METTL14 knockdown HepG2 cells

| PRJNA499122 | ENA

Active ribosome profiling in SETD2 or METTL14 knockdown HepG2 cells

Project description:Active ribosome profiling in SETD2 or METTL14 knockdown HepG2 cells

| PRJNA501872 | ENA

Profiling of N6-methyladenosine in HepG2 cells: SETD2, METTL3, METTL14 or WTAP knockdown and control cells

Project description:SETD2 is the specific methyltransferase of H3K36me3, while METTL3, METTL14 and WTAP are the components of m6A methyltransferase complex. To understand the global effect of H3K36me3 on m6A modification, we compared the m6A profiling in SETD2 and METTL3, METTL14 or WTAP knockdown HepG2 cells, and found depletion of H3K36me3 by SETD2 silencing globally reduced m6A in human transcriptome. What’s more, most of the SETD2-dependent hypomethylation sites also responded to knockdown of METTL3, METTL14, or WTAP.

2019-02-21 | GSE110320 | GEO

ChIP-Seq MyT1-HA in NS5

Project description:ChIP-Seq MyT1-HA in NS5

| PRJEB12654 | ENA

ChIP-seq in liver cancer HepG2 cells

Project description:ChIP-seq in liver cancer HepG2 cells

| PRJNA542691 | ENA